Table 1.
Clinical data after radiofrequency ablation of atrial fibrillation.
| Recurrence (n = 27) | Non-recurrence (n = 56) | P | |
|---|---|---|---|
| Age (y) | 63.26 ± 9.30 | 58.96 ± 10.26 | 0.069 |
| Sex (males) | 15(55.6%) | 34(60.7%) | 0.654 |
| BMI (kg/m2) | 26.12 ± 3.63 | 25.90 ± 4.28 | 0.818 |
| Diabetes Mellitus | 4(14.8%) | 4(7.1%) | 0.476 |
| Hypertension | 15(55.6%) | 26(46.4%) | 0.436 |
| Coronary heart disease | 14(51.9%) | 23(41.1%) | 0.355 |
| Stroke/TIA | 2(7.4%) | 9(16.1%) | 0.456 |
| Heart failure | 11(40.7%) | 7(12.5%) | 0.003 |
| LVEF | 61.86(60.80,62.50) | 61.47(60.78,62.50) | 0.818 |
| CHA2DS2-VASc | 3.00(3.00,4.00) | 2.00(1.00, 4.00) | 0.013 |
| AF duration (months) | 24.00(8, 60) | 24.00(6.25,36.00) | 0.398 |
Note: AF, atrial fibrillation; BMI, body mass index; TIA, transient ischemic attack; LVEF, left ventricular ejection fraction.